Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2007;116:1128-1136
Published online before print August 20, 2007, doi: 10.1161/CIRCULATIONAHA.107.710780
CLINICAL PERSPECTIVE
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction
Right arrow Correction (v117,pe9)
Right arrow All Versions of this Article:
116/10/1128    most recent
CIRCULATIONAHA.107.710780v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newton-Cheh, C.
Right arrow Articles by O’Donnell, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newton-Cheh, C.
Right arrow Articles by O’Donnell, C. J.
Related Collections
Right arrow Electrophysiology
Right arrow Clinical genetics
Right arrow Electrocardiology
Right arrow Epidemiology

(Circulation. 2007;116:1128-1136.)
© 2007 American Heart Association, Inc.

Genetics

CLINICAL PERSPECTIVE

Disordered myocardial repolarization as manifest in electrocardiographic QT interval prolongation is a consistent risk factor for sudden cardiac death. As a consequence of noncardiac medications, QT prolongation and arrhythmias, in part a result of binding to the HERG channel, are also a major impediment to bringing common drugs to market safely. We tested common genetic variants in the KCNH2 gene encoding the {alpha} subunit of the HERG channel and observed association of a novel intronic single nucleotide polymorphism and a previously reported missense single nucleotide polymorphism with continuous QT interval duration in the Framingham Heart Study. The variants contribute to modest changes in QT interval, 3.9- and 3.1-ms increases; thus, their relevance to clinical disease is currently unclear. In trials of drugs that prolong the QT interval on resting ECG, increases of 5 to 10 ms in the group mean have been associated with increased risk of arrhythmia. These group means on resting ECGs reflect some patients with little QT change and some with substantial increases who likely bear a large fraction of risk. Future tests of common variants of modest effect such as those in KCNH2 or the recently identified NOS1AP myocardial repolarization gene ({approx}7-ms increase) in individuals at high risk for arrhythmias (eg, heart failure, status post myocardial infarction) and those exposed to QT-prolonging drugs are needed to determine whether these small changes in group means hide substantially increased risk for certain individuals when combined with other repolarization perturbations.


*    Footnotes
 
Guest Editor for this article was Michael E. Cain, MD.

The online Data Supplement, consisting of tables and a figure, can be found with this article at http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.107.710780/DC1.

*Dr Hirschhorn and Dr O’Donnell contributed equally. Back

Presented in part at the 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention of the American Heart Association, Washington, DC, May 2005.




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
M. Eijgelsheim, A. L.H.J. Aarnoudse, F. Rivadeneira, J. A. Kors, J. C. M. Witteman, A. Hofman, C. M. van Duijn, A. G. Uitterlinden, and B. H.C. Stricker
Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration
Hum. Mol. Genet., January 15, 2009; 18(2): 347 - 357.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. A. Noseworthy and C. Newton-Cheh
Genetic Determinants of Sudden Cardiac Death
Circulation, October 28, 2008; 118(18): 1854 - 1863.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. T. Ellinor and D. J. Milan
Polymorphisms and atrial fibrillation: sorting the wheat from the chaff
Eur. Heart J., April 1, 2008; 29(7): 843 - 845.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction
Right arrow Correction (v117,pe9)
Right arrow All Versions of this Article:
116/10/1128    most recent
CIRCULATIONAHA.107.710780v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newton-Cheh, C.
Right arrow Articles by O’Donnell, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newton-Cheh, C.
Right arrow Articles by O’Donnell, C. J.
Related Collections
Right arrow Electrophysiology
Right arrow Clinical genetics
Right arrow Electrocardiology
Right arrow Epidemiology

Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.